Jessica Zhang

Jessica (Xiangyu) Zhang is a highly skilled professional in the biotechnology and neuroscience fields, currently serving as a Senior Associate at OrbiMed since September 2022. Prior experience includes an Associate role at 6 Dimensions Capital and a Research Scientist position at Vertex Pharmaceuticals, where Jessica contributed significantly to the development of a second-generation gene-editing platform using CRISPR/Cas9 technology. Jessica's academic qualifications include a PhD in Neuroscience from the Massachusetts Institute of Technology, where research focused on the neuronal mechanisms of emotional behaviors and psychiatric diseases, and a Bachelor’s degree in Life Sciences from Peking University.